Suiyi Wu

Construction and Validation of an Epigenetic Regulator Signature as A Novel Biomarker For Prognosis, Immunotherapy, And Chemotherapy In Hepatocellular Carcinoma

Feng Zhang, Z. Dai, Jialiang Cai, 2022, Frontiers in Immunology.

CD13 promotes hepatocellular carcinogenesis and sorafenib resistance by activating HDAC5‐LSD1‐NF‐κB oncogenic signaling

Bo Hu, Jia Fan, Jian Zhou, 2020, Clinical and translational medicine.

Detection of circulating tumour cells enables early recurrence prediction in hepatocellular carcinoma patients undergoing liver transplantation

Ya Cao, Bo Hu, Jia Fan, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Interferon-a potentiates anti-PD-1 efficacy by remodeling glucose metabolism in the hepatocellular carcinoma microenvironment.

A. Zhu, S. Qiu, Bo Hu, 2022, Cancer discovery.

Mucin 1 promotes tumor progression through activating WNT/β-catenin signaling pathway in intrahepatic cholangiocarcinoma

Bo Hu, Jia Fan, Jian Zhou, 2021, Journal of Cancer.

Circulating tumor cell detection and single‐cell analysis using an integrated workflow based on ChimeraX®‐i120 Platform: A prospective study

Ya Cao, W. Guo, Bo Hu, 2020, Molecular oncology.